Neurodegenerative disorders (NDs) affect a great number of people worldwide and also
have a significant socio-economic impact on the aging population. In this context …

By introducing biomaterials and stem cells into Parkinson's disease (PD), therapeutic
approaches have led to promising results due to facilitating brain targeting and blood–brain …

The demand for drug delivery systems (DDS) to treat Parkinson's disease (PD) is still high,
and microneedle (MN) assisted transdermal DDS offers enormous potential. Herbal …

Neurodegenerative diseases are assorted clusters of ailments marked by the developing
degeneration of the composition and activity of the central or peripheral nervous system …

Even though Parkinson's disease (PD) is the second most common neurological disorder
(ND), it faces an absence of credible drug delivery, treatment and diagnosis. Levodopa is …

Polymeric nanoparticles (PNPs) are a group of nanocarriers employed in a wide range of
applications. Characterization is a fundamental step in PNPs formulation and many basic …

The heterogeneity of symptoms and disease progression observed in synucleinopathies, of
which Parkinson's disease (PD) is the most common representative, poses large problems …

Alzheimer's disease (AD), the most common form of dementia, is a progressive and
multifactorial neurodegenerative disorder whose primary causes are mostly unknown. Due …

This study presents an alternative therapy to conventional anti-Parkinson's treatment
strategies; where motor and non-motor symptomatic complications are considered. Thus; …

Parkinson's disease (PD) is a progressive neurodegenerative disorder primarily affecting
elderly patients. In order to efficiently manage the symptoms of the disease, controlled and …